Abstract:Objective: The escalating challenge posed by multidrug-resistant tuberculosis (MDR-TB) necessitates the discovery of potent treatment agents. This study aims to synthesize, characterize, and evaluate the antitubercular potential of 33 novel 2,3-(4-aminobenzamido)benzoic acid derivatives ( 1–33 ). Methods: The synthesis involved a three-stage reaction series starting with p -aminobenzoic acid treated with concentrated hydrochloric acid to obtain its salt. This was further modified to ammonium benzoyl chloride using thionyl chloride. The ammonium benzoyl chloride was then condensed with 2 or 3 benzoic acids to yield the desired 2,3-(4-aminobenzamido)benzoic acid derivatives. The structures of these compounds were elucidated using FT-IR, HR-MS, 1 H, and 13 C NMR. Their antituberculosis activity was assessed using the Alamar blue dye assay against Mycobacterium tuberculosis H37RV. Results and Discussion: Out of the 33 synthesized compounds, 12 showed sensitivity to Mycobacterium tuberculosis (MTB). Notably, five compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) demonstrated significant potency, with minimal inhibitory concentrations (MICs) of 1.6 μg/mL, nearly 50 times lower than the standard drug. These results strongly suggest the potential of these compounds as effective tuberculosis therapeutics. Conclusions: The synthesized series of 2,3-(4-aminobenzamido)benzoic acid derivatives have shown promising antituberculosis activity. Specifically, compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) exhibited noteworthy potency. It is crucial that future research focuses on further screening the active compounds ( 2 – 4 ), ( 10 ), ( 14 ), ( 18 ), ( 19 ), ( 21 ), ( 26 ), ( 28 ), ( 30 ), and ( 33 ) for antimicrobial strains and evaluating compounds ( 14 ), ( 18 ), ( 19 ), ( 26 ), and ( 30 ) using the DHFR enzyme-specific assay to advance the development of effective tuberculosis treatments.

The Optimization and Characterization of Functionalized Sulfonamides Derived from Sulfaphenazole Against Mycobacterium Tuberculosis with Reduced CYP 2C9 Inhibition

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Synthesis and structure-activity relationships of aryl fluorosulfate-based inhibitors as novel antitubercular agents

Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase B

Design, Synthesis, and Evaluation of the Antitubercular Activity of 5-Phenyl Substituted-5, 6-dihydropyrido[2, 3- d ]pyrimidine-4, 7( 3H , 8H )-dione Compounds

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation

Synthesis, Antitubercular Evaluation of New 2,3-(4-Aminobenzamido)benzoic Acid Derivatives

Synthesis and Evaluation of (S,S)-N,N '-Bis-[3-(2,2 ',6,6 '-Tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) Analogs with Anti-Tuberculosis Activity

QSAR Modeling, Molecular Docking and ADMET Study of Aryl Fluorosulfate Derivatives as Potential Anti-TB Agents

Design, synthesis and biological evaluation of diamino substituted cyclobut-3-ene-1,2-dione derivatives for the treatment of drug-resistant tuberculosis

Design, Synthesis, and Evaluation of Novel Δ2-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant Mycobacterium tuberculosis Mutant

New Synergistic Benzoquinone Scaffolds as Inhibitors of Mycobacterial Cytochrome bc1 Complex to Treat Multi-Drug Resistant Tuberculosis

Solubility-driven optimization of benzothiopyranone salts leading to a preclinical candidate with improved pharmacokinetic properties and activity against Mycobacterium tuberculosis

Synthesis and Anti-Tubercular Activity of Novel Alkyl Substituted Riminophenazine Derivatives.

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Design, Synthesis and Anti-Mycobacterial Activity Evaluation of Benzofuran-Isatin Hybrids.

Synthesis, crystal structure, density functional theory, drug-likeness, and molecular docking studies of a new carbazole-pyrazole derivative: A potential inhibitor of tuberculosis

Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents

Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents

Synthesis and Biological Evaluation of Moxifloxacin-Acetyl-1,2,3-1h-triazole-methylene-isatin Hybrids As Potential Anti-Tubercular Agents Against Both Drug-Susceptible and Drug-Resistant Mycobacterium Tuberculosis Strains.